Related references
Note: Only part of the references are listed.Phosphorylation Regulates c-Myc's Oncogenic Activity in the Mammary Gland
Xiaoyan Wang et al.
CANCER RESEARCH (2011)
Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation
Per Hydbring et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Immortalization and transformation of human mammary epithelial cells by a tumor-derived Myc mutant
Clare A. Thibodeaux et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
The Axin1 scaffold protein promotes formation of a degradation complex for c-Myc
Hugh K. Arnold et al.
EMBO JOURNAL (2009)
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer
Baozhi Chen et al.
NATURE CHEMICAL BIOLOGY (2009)
Distinct Thresholds Govern Myc's Biological Output In Vivo
Daniel J. Murphy et al.
CANCER CELL (2008)
Modelling Myc inhibition as a cancer therapy
Laura Soucek et al.
NATURE (2008)
MYC - TIMELINE Reflecting on 25 years with MYC
Natalie Meyer et al.
NATURE REVIEWS CANCER (2008)
The ever expanding role for c-Myc in promoting genomic instability
Edward V. Prochownik et al.
CELL CYCLE (2007)
A conserved pathway that controls c-Myc protein stability through opposing phosphorylation events occurs in yeast
Julienne R. Escamilia-Powers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Aberrant stabilization of c-Myc protein in some lymphoblastic leukemias
S. Malempati et al.
LEUKEMIA (2006)
MYC levels govern hernatopoietic tumor type and latency in transgenic mice
Darrin P. Smith et al.
BLOOD (2006)
Axin is a scaffold protein in TGF-β signaling that promotes degradation of Smad7 by Arkadia
Wei Liu et al.
EMBO JOURNAL (2006)
c-Myc phosphorylation is required for cellular response to oxidative stress
B Benassi et al.
MOLECULAR CELL (2006)
Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants
MT Hemann et al.
NATURE (2005)
The links between axin and carcinogenesis
S Salahshor et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer:: FISH, in situ hybridisation and immunohistochemical analyses
J Blancato et al.
BRITISH JOURNAL OF CANCER (2004)
A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells
E Yeh et al.
NATURE CELL BIOLOGY (2004)
The life cycle of C-myc - From synthesis to degradation
RC Sears
CELL CYCLE (2004)
Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation
YN Rui et al.
EMBO JOURNAL (2004)
The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation
M Welcker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Impaired mammary gland and lymphoid development caused by inducible expression of Axin in transgenic mice
W Hsu et al.
JOURNAL OF CELL BIOLOGY (2001)
c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations
CM D'Cruz et al.
NATURE MEDICINE (2001)
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
S Satoh et al.
NATURE GENETICS (2000)